Oseltamivir prescription practices during the 2017-2018 influenza season

الملخص EN

Background : influenza is an acute contagious respiratory illness caused by influenza A and B viruses worldwide.

influenza is estimated to cause approximately three to five million severe illnesses and 250,000-350,000 deaths annually.

it is considered an economic burden costing approximately $87.1 billion annually.

the use of oseltamivir can act as a chemo prophylactic and therapeutic agent to reduce the duration and severity of the infection.

Objective : to review and analyze influenza cases treated with oseltamivir during the influenza season of 2017-2018.

Design : a retrospective cross-sectional study.

Setting : king hamad university hospital, Bahrain.